Use of Meriva as complementary therapy of locally advanced or metastatic pancreatic cancer (PC) with gemcitabine (GEM).

被引：1
|
作者：
Solda, Caterina
Sperti, Cosimo
Romeo, Bardini
Da Dalt, Gianfranco
Gion, Massimo
Ursini, Fulvio
Fiduccia, Pasquale
Aliberti, Camillo
Pastorelli, Davide
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e15696
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15696
引用
收藏
页数：2
相关论文
共 50 条
  • [41] GEMCITABINE FOLLOWED BY CONCURRENT CHEMORADIOTHERAPY FOR LOCALLY ADVANCED PANCREATIC CANCER
    Yasui, H.
    Okazaki, S.
    Tanaka, M.
    Araki, N.
    ANNALS OF ONCOLOGY, 2013, 24
  • [42] STEREOTACTIC BODY RADIOTHERAPY AND GEMCITABINE FOR LOCALLY ADVANCED PANCREATIC CANCER
    Mahadevan, Anand
    Jain, Sanjay
    Goldstein, Michael
    Miksad, Rebecca
    Pleskow, Douglas
    Sawhney, Mandeep
    Brennan, Darren
    Callery, Mark
    Vollmer, Charles
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : 735 - 742
  • [43] Gemcitabine-radiotherapy in patients with locally advanced pancreatic cancer
    de Lange, SM
    van Groeningen, CJ
    Meijer, OWM
    Cuesta, MA
    Langendijk, JA
    van Riel, JMGH
    Pinedo, HM
    Peters, GJ
    Meijer, S
    Slotman, BJ
    Giaccone, G
    EUROPEAN JOURNAL OF CANCER, 2002, 38 (09) : 1212 - 1217
  • [44] Gemcitabine combined with radiation for the treatment of locally advanced pancreatic cancer
    Ishihara, Shin
    Horiguchi, Akihiko
    Ito, Masahiro
    Nagata, Hideo
    Asano, Yukio
    Yamamoto, Toshiyuki
    Tsuda, Kazuki
    Morigaki, Satoko
    Shimura, Masahiro
    Miyakawa, Shuichi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 : A248 - A248
  • [45] Second-line therapy for gemcitabine-pretreated advanced or metastatic pancreatic cancer
    Altwegg, Romain
    Ychou, Marc
    Guillaumon, Vanessa
    Thezenas, Simon
    Senesse, Pierre
    Flori, Nicolas
    Mazard, Thibault
    Caillo, Ludovic
    Faure, Stephanie
    Samalin, Emmanuelle
    Assenat, Eric
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (12) : 1357 - 1364
  • [46] Clinical benefit with gemcitabine (GEM) as first-line therapy for patients with advanced pancreatic cancer (APC)
    Manzano, H
    Esquerdo, G
    Rifa, J
    Aguiar, D
    Arrivi, A
    Pazo, R
    Martin, J
    Terrasa, J
    ANNALS OF ONCOLOGY, 1998, 9 : 54 - 54
  • [47] Second-line therapy for gemcitabine-pretreated advanced or metastatic pancreatic cancer
    Romain Altwegg
    Marc Ychou
    Vanessa Guillaumon
    Simon Thezenas
    Pierre Senesse
    Nicolas Flori
    Thibault Mazard
    Ludovic Caillo
    Stéphanie Faure
    Emmanuelle Samalin
    Eric Assenat
    World Journal of Gastroenterology, 2012, (12) : 1357 - 1364
  • [48] A pilot study of gemcitabine (g), oxaliplatin (o), cetuximab (c) for locally advanced or metastatic pancreatic cancer
    Merchan, J. R.
    Venkatraman, A.
    Macintyre, J.
    Ciombor, K.
    Levi, J.
    Ribeiro, A.
    Sleeman, D.
    Aurea, F.
    Vulfovich, M.
    Rocha-Lima, C. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [49] Phase I study of combination of pasireotide LAR plus gemcitabine in locally advanced or metastatic pancreatic cancer
    Suleiman, Yaman
    Mahipal, Amit
    Shibata, David
    Siegel, Erin M.
    Jump, Helen
    Fulp, William J.
    Springett, Gregory M.
    Kim, Richard
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (03) : 481 - 487
  • [50] EUS-Guided Intratumoral Gemcitabine Injection in Locally Advanced Non-Metastatic Pancreatic Cancer
    Mohamadnejad, Mehdi
    Zamani, Farhad
    Setareh, Mehrnoosh
    Nikfam, Sepideh
    Malekzadeh, Reza
    GASTROINTESTINAL ENDOSCOPY, 2015, 81 (05) : AB440 - AB441
12345